Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.

Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment. Abstract Text:

Adam Whaley-Connell,Javad Habibi,Ravi Nistala,Shawna A Cooper,Poorna R Karuparthi,Melvin R Hayden,Nathan Rehmer,Vincent G Demarco,Bradley T Andresen,Yongzhong Wei,Carlos Ferrario,James R Sowers,Adam Whaley-Connell,Javad Habibi,Ravi Nistala,Shawna A Cooper,Poorna R Karuparthi,Melvin R Hayden,Nathan Rehmer,Vincent G DeMarco,Bradley T Andresen,Yongzhong Wei,Carlos Ferrario,James R Sowers,

Activation of reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase by angiotensin II is integral to the formation of oxidative stress in the vasculature and the kidney. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibition is associated with reductions of oxidative stress in the vasculature and kidney and associated decreases in albuminuria. Effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibition on oxidative stress in the kidney and filtration barrier integrity are poorly understood. To investigate, we used transgenic TG(mRen2)27 (Ren2) rats, which harbor the mouse renin transgene and renin-angiotensin system activation, and an immortalized murine podocyte cell line. We treated young, male Ren2 and Sprague-Dawley rats with rosuvastatin (20 mg/kg IP) or placebo for 21 days. Compared with controls, we observed increases in systolic blood pressure, albuminuria, renal NADPH oxidase activity, and 3-nitrotryosine staining, with reductions in the rosuvastatin-treated Ren2. Structural changes on light and transmission electron microscopy, consistent with periarteriolar fibrosis and podocyte foot-process effacement, were attenuated with statin treatment. Nephrin expression was diminished in the Ren2 kidney and trended to normalize with statin treatment. Angiotensin II-dependent increases in podocyte NADPH oxidase activity and subunit expression (NOX2, NOX4, Rac, and p22(phox)) and reactive oxygen species generation were decreased after in vitro statin treatment. These data support a role for increased NADPH oxidase activity and subunit expression with resultant reactive oxygen species formation in the kidney and podocyte. Furthermore, statin attenuation of NADPH oxidase activation and reactive oxygen species formation in the kidney/podocyte seems to play roles in the abrogation of oxidative stress-induced filtration barrier injury and consequent albuminuria.

Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment. Publishing Authors By Initials

A Whaley-Connell,J Habibi,R Nistala,SA Cooper,PR Karuparthi,MR Hayden,N Rehmer,VG Demarco,BT Andresen,Y Wei,C Ferrario,JR Sowers,A Whaley-Connell,J Habibi,R Nistala,SA Cooper,PR Karuparthi,MR Hayden,N Rehmer,VG DeMarco,BT Andresen,Y Wei,C Ferrario,JR Sowers,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Hypertension

VOLUME: 51

Page Numbers: 474-80

Journal Abbreviation: Hypertension

ISSN: 1524-4563

DAY: 2

MONTH: 01

YEAR: 2008

Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7906255

Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.

AFFILIATION: University of Missouri-Columbia School of Medicine, Department of Internal Medicine, Division of Nephrology, MA436, DC043.0, One Hospital Dr, Columbia, MO 65212. whaleyconnella@health.missouri.edu.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hypertension

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment Related Publications

• Albumin activation of NAD(P)H oxidase activity is mediated via Rac1 in proximal tubule cells.
• Alcohol consumption and blood pressure in the adult US population: assessment of gender-related effects.
• Aldosterone and hypertension in the cardiometabolic syndrome.
• Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
• Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.
• Corticosteroid modulation of the renin system and blood pressure in the spontaneously hypertensive rat.
• Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1.
• Essentials of a Workable Merit System.
• Index Medicus update.
• Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers.
• Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury.
• Introduction: organ involvement in the cardiometabolic syndrome.
• Isletopathy in Type 2 diabetes mellitus: implications of islet RAS, islet fibrosis, islet amyloid, remodeling, and oxidative stress.
• Longitudinal ultrastructure study of islet amyloid in the HIP rat model of type 2 diabetes mellitus.
• Measurement of the Incorporation and Repair of Exogenous 5-Hydroxymethyl-2'-deoxyuridine in Human Cells in Culture Using Gas Chromatography-Negative Chemical Ionization-Mass Spectrometry.
• Methods in the evaluation of cardiovascular Renin Angiotensin aldosterone activation and oxidative stress.
• Microalbuminuria and proximal tubule remodeling in the cardiometabolic syndrome.
• Microbial reductive dechlorination of aroclor 1260 in Baltimore harbor sediment microcosms is catalyzed by three phylotypes within the phylum Chloroflexi.
• Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
• Myocardial myocyte remodeling and fibrosis in the cardiometabolic syndrome.
• NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat.
• Obesity, insulin resistance, and nocturnal systolic blood pressure.
• Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
• Physiology of early ambulation.
• Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.
• Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats.
• Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species.
• The metabolic syndrome: role of skeletal muscle metabolism.
• Two-stage functional mixed models for evaluating the effect of longitudinal covariate profiles on a scalar outcome.
• Ultrastructural islet study of early fibrosis in the Ren2 rat model of hypertension. Emerging role of the islet pancreatic pericyte-stellate cell.